-
2
-
-
79961021004
-
Pancreatic cancer surgery in the new millennium: better prediction of outcome
-
Hartwig W, Hackert T, Hinz U, Gluth A, Bergmann F, Strobel O, Buchler MW, Werner J. 2011. Pancreatic cancer surgery in the new millennium: better prediction of outcome. Ann. Surg. 254:311-319. http://dx.doi.org/10.1097/SLA.0b013e31821fd334.
-
(2011)
Ann. Surg.
, vol.254
, pp. 311-319
-
-
Hartwig, W.1
Hackert, T.2
Hinz, U.3
Gluth, A.4
Bergmann, F.5
Strobel, O.6
Buchler, M.W.7
Werner, J.8
-
3
-
-
77951709577
-
Preoperative/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentages
-
Gillen S, Schuster T, Meyer Zum Buschenfelde C, Friess H, Kleeff J. 2010. Preoperative/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentages. PLoS Med. 7:e1000267. http://dx.doi.org/10.1371/journal.pmed.1000267.
-
(2010)
PLoS Med.
, vol.7
-
-
Gillen, S.1
Schuster, T.2
Meyer Zum Buschenfelde, C.3
Friess, H.4
Kleeff, J.5
-
4
-
-
0036623140
-
Immune escape of tumors: apoptosis resistance and tumor counterattack
-
Igney FH, Krammer PH. 2002. Immune escape of tumors: apoptosis resistance and tumor counterattack. J. Leukoc. Biol. 71:907-920.
-
(2002)
J. Leukoc. Biol.
, vol.71
, pp. 907-920
-
-
Igney, F.H.1
Krammer, P.H.2
-
5
-
-
65549136785
-
Countering tumor-induced immunosuppression during immunotherapy for pancreatic cancer
-
Morse MA, Hall JR, Plate JM. 2009. Countering tumor-induced immunosuppression during immunotherapy for pancreatic cancer. Expert Opin. Biol. Ther. 9:331-339. http://dx.doi.org/10.1517/14712590802715756.
-
(2009)
Expert Opin. Biol. Ther.
, vol.9
, pp. 331-339
-
-
Morse, M.A.1
Hall, J.R.2
Plate, J.M.3
-
6
-
-
33747748129
-
Cooperative induction of a tolerogenic dendritic cell phenotype by cytokines secreted by pancreatic carcinoma cells
-
Bellone G, Carbone A, Smirne C, Scirelli T, Buffolino A, Novarino A, Stacchini A, Bertetto O, Palestro G, Sorio C, Scarpa A, Emanuelli G, Rodeck U. 2006. Cooperative induction of a tolerogenic dendritic cell phenotype by cytokines secreted by pancreatic carcinoma cells. J. Immunol. 177:3448-3460.
-
(2006)
J. Immunol
, vol.177
, pp. 3448-3460
-
-
Bellone, G.1
Carbone, A.2
Smirne, C.3
Scirelli, T.4
Buffolino, A.5
Novarino, A.6
Stacchini, A.7
Bertetto, O.8
Palestro, G.9
Sorio, C.10
Scarpa, A.11
Emanuelli, G.12
Rodeck, U.13
-
7
-
-
68849086119
-
Anticancer immunochemotherapy using adjuvants with direct cytotoxic effects
-
Zitvogel L, Kroemer G. 2009. Anticancer immunochemotherapy using adjuvants with direct cytotoxic effects. J. Clin. Invest. 119:2127-2130. http://dx.doi.org/10.1172/JCI39991.
-
(2009)
J. Clin. Invest.
, vol.119
, pp. 2127-2130
-
-
Zitvogel, L.1
Kroemer, G.2
-
9
-
-
79952280438
-
Molecular determinants of immunogenic cell death elicited by anticancer chemotherapy
-
Kepp O, Galluzzi L, Martins I, Schlemmer F, Adjemian S, Michaud M, Sukkurwala AQ, Menger L, Zitvogel L, Kroemer G. 2011. Molecular determinants of immunogenic cell death elicited by anticancer chemotherapy. Cancer Metastasis Rev. 30:61-69. http://dx.doi.org/10.1007/s10555-011-9273-4.
-
(2011)
Cancer Metastasis Rev.
, vol.30
, pp. 61-69
-
-
Kepp, O.1
Galluzzi, L.2
Martins, I.3
Schlemmer, F.4
Adjemian, S.5
Michaud, M.6
Sukkurwala, A.Q.7
Menger, L.8
Zitvogel, L.9
Kroemer, G.10
-
10
-
-
79952390627
-
Immune parameters affecting the efficacy of chemotherapeutic regimens
-
Zitvogel L, Kepp O, Kroemer G. 2011. Immune parameters affecting the efficacy of chemotherapeutic regimens. Nat. Rev. Clin. Oncol. 8:151- 160. http://dx.doi.org/10.1038/nrclinonc.2010.223.
-
(2011)
Nat. Rev. Clin. Oncol.
, vol.8
, pp. 151-160
-
-
Zitvogel, L.1
Kepp, O.2
Kroemer, G.3
-
11
-
-
78549275158
-
Improved clinical outcome in indolent B-cell lymphoma patients vaccinated with autologous tumor cells experiencing immunogenic death
-
Zappasodi R, Pupa SM, Ghedini GC, Bongarzone I, Magni M, Cabras AD, Colombo MP, Carlo-Stella C, Gianni AM, Di Nicola M. 2010. Improved clinical outcome in indolent B-cell lymphoma patients vaccinated with autologous tumor cells experiencing immunogenic death. Cancer Res. 70:9062-9072. http://dx.doi.org/10.1158/0008-5472.CAN-10-1825.
-
(2010)
Cancer Res.
, vol.70
, pp. 9062-9072
-
-
Zappasodi, R.1
Pupa, S.M.2
Ghedini, G.C.3
Bongarzone, I.4
Magni, M.5
Cabras, A.D.6
Colombo, M.P.7
Carlo-Stella, C.8
Gianni, A.M.9
Di Nicola, M.10
-
12
-
-
84857954861
-
Chemotherapy response of spontaneous mammary tumors is independent of the adaptive immune system
-
Ciampricotti M, Hau CS, Doornebal CW, Jonkers J, de Visser KE. 2012. Chemotherapy response of spontaneous mammary tumors is independent of the adaptive immune system. Nat. Med. 18:344-346. http://dx.doi.org/10.1038/nm.2652.
-
(2012)
Nat. Med.
, vol.18
, pp. 344-346
-
-
Ciampricotti, M.1
Hau, C.S.2
Doornebal, C.W.3
Jonkers, J.4
De Visser, K.E.5
-
13
-
-
83755181759
-
Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice
-
Michaud M, Martins I, Sukkurwala AQ, Adjemian S, Ma Y, Pellegatti P, Shen S, Kepp O, Scoazec M, Mignot G, Rello-Varona S, Tailler M, Menger L, Vacchelli E, Galluzzi L, Ghiringhelli F, di Virgilio F, Zitvogel L, Kroemer G. 2011. Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice. Science 334:1573-1577. http://dx.doi.org/10.1126/science.1208347.
-
(2011)
Science
, vol.334
, pp. 1573-1577
-
-
Michaud, M.1
Martins, I.2
Sukkurwala, A.Q.3
Adjemian, S.4
Ma, Y.5
Pellegatti, P.6
Shen, S.7
Kepp, O.8
Scoazec, M.9
Mignot, G.10
Rello-Varona, S.11
Tailler, M.12
Menger, L.13
Vacchelli, E.14
Galluzzi, L.15
Ghiringhelli, F.16
di Virgilio, F.17
Zitvogel, L.18
Kroemer, G.19
-
14
-
-
79960406242
-
Human tumor cells killed by anthracyclines induce a tumor-specific immune response
-
Fucikova J, Kralikova P, Fialova A, Brtnicky T, Rob L, Bartunkova J, Spisek R. 2011. Human tumor cells killed by anthracyclines induce a tumor-specific immune response. Cancer Res. 71:4821-4833. http://dx.doi.org/10.1158/0008-5472.CAN-11-0950.
-
(2011)
Cancer Res.
, vol.71
, pp. 4821-4833
-
-
Fucikova, J.1
Kralikova, P.2
Fialova, A.3
Brtnicky, T.4
Rob, L.5
Bartunkova, J.6
Spisek, R.7
-
15
-
-
79952533264
-
Restoration of the immunogenicity of cisplatininduced cancer cell death by endoplasmic reticulum stress
-
Martins I, Kepp O, Schlemmer F, Adjemian S, Tailler M, Shen S, Michaud M, Menger L, Gdoura A, Tajeddine N, Tesniere A, Zitvogel L, Kroemer G. 2011. Restoration of the immunogenicity of cisplatininduced cancer cell death by endoplasmic reticulum stress. Oncogene 30:1147-1158. http://dx.doi.org/10.1038/onc.2010.500.
-
(2011)
Oncogene
, vol.30
, pp. 1147-1158
-
-
Martins, I.1
Kepp, O.2
Schlemmer, F.3
Adjemian, S.4
Tailler, M.5
Shen, S.6
Michaud, M.7
Menger, L.8
Gdoura, A.9
Tajeddine, N.10
Tesniere, A.11
Zitvogel, L.12
Kroemer, G.13
-
16
-
-
22244489353
-
Effect of gemcitabine on immune cells in subjects with adenocarcinoma of the pancreas
-
Plate JM, Plate AE, Shott S, Bograd S, Harris JE. 2005. Effect of gemcitabine on immune cells in subjects with adenocarcinoma of the pancreas. Cancer Immunol. Immunother. 54:915-925. http://dx.doi.org/10.1007/s00262-004-0638-1.
-
(2005)
Cancer Immunol. Immunother.
, vol.54
, pp. 915-925
-
-
Plate, J.M.1
Plate, A.E.2
Shott, S.3
Bograd, S.4
Harris, J.E.5
-
17
-
-
67649422143
-
Impact of surgery and chemotherapy on cellular immunity in pancreatic carcinoma patients in view of an integration of standard cancer treatment with immunotherapy
-
Bellone G, Novarino A, Vizio B, Brondino G, Addeo A, Prati A, Giacobino A, Campra D, Fronda GR, Ciuffreda L. 2009. Impact of surgery and chemotherapy on cellular immunity in pancreatic carcinoma patients in view of an integration of standard cancer treatment with immunotherapy. Int. J. Oncol. 34:1701-1715. http://dx.doi.org/10.3892/ijo_00000301.
-
(2009)
Int. J. Oncol.
, vol.34
, pp. 1701-1715
-
-
Bellone, G.1
Novarino, A.2
Vizio, B.3
Brondino, G.4
Addeo, A.5
Prati, A.6
Giacobino, A.7
Campra, D.8
Fronda, G.R.9
Ciuffreda, L.10
-
18
-
-
34548130212
-
Dendritic cell-based vaccination combined with gemcitabine increases survival in a murine pancreatic carcinoma model
-
Bauer C, Bauernfeind F, Sterzik A, Orban M, Schnurr M, Lehr HA, Endres S, Eigler A, Dauer M. 2007. Dendritic cell-based vaccination combined with gemcitabine increases survival in a murine pancreatic carcinoma model. Gut 56:1275-1282. http://dx.doi.org/10.1136/gut.2006.108621.
-
(2007)
Gut
, vol.56
, pp. 1275-1282
-
-
Bauer, C.1
Bauernfeind, F.2
Sterzik, A.3
Orban, M.4
Schnurr, M.5
Lehr, H.A.6
Endres, S.7
Eigler, A.8
Dauer, M.9
-
19
-
-
79960900889
-
Dendritic cell-based vaccination of patients with advanced pancreatic carcinoma: results of a pilot study
-
Bauer C, Dauer M, Saraj S, Schnurr M, Bauernfeind F, Sterzik A, Junkmann J, Jakl V, Kiefl R, Oduncu F, Emmerich B, Mayr D, Mussack T, Bruns C, Ruttinger D, Conrad C, Jauch KW, Endres S, Eigler A. 2011. Dendritic cell-based vaccination of patients with advanced pancreatic carcinoma: results of a pilot study. Cancer Immunol. Immunother. 60:1097- 1107. http://dx.doi.org/10.1007/s00262-011-1023-5.
-
(2011)
Cancer Immunol. Immunother.
, vol.60
, pp. 1097-1107
-
-
Bauer, C.1
Dauer, M.2
Saraj, S.3
Schnurr, M.4
Bauernfeind, F.5
Sterzik, A.6
Junkmann, J.7
Jakl, V.8
Kiefl, R.9
Oduncu, F.10
Emmerich, B.11
Mayr, D.12
Mussack, T.13
Bruns, C.14
Ruttinger, D.15
Conrad, C.16
Jauch, K.W.17
Endres, S.18
Eigler, A.19
-
20
-
-
21844463061
-
Chemosensitization of pancreatic carcinoma cells to enhance T cell-mediated cytotoxicity induced by tumor lysate-pulsed dendritic cells
-
Dauer M, Herten J, Bauer C, Renner F, Schad K, Schnurr M, Endres S, Eigler A. 2005. Chemosensitization of pancreatic carcinoma cells to enhance T cell-mediated cytotoxicity induced by tumor lysate-pulsed dendritic cells. J. Immunother. 28:332-342. http://dx.doi.org/10.1097/01.cji.0000164038.41104.f5.
-
(2005)
J. Immunother.
, vol.28
, pp. 332-342
-
-
Dauer, M.1
Herten, J.2
Bauer, C.3
Renner, F.4
Schad, K.5
Schnurr, M.6
Endres, S.7
Eigler, A.8
-
21
-
-
34547160717
-
Biology and management of pancreatic cancer
-
Ghaneh P, Costello E, Neoptolemos JP. 2007. Biology and management of pancreatic cancer. Gut 56:1134-1152. http://dx.doi.org/10.1136/gut.2006.103333.
-
(2007)
Gut
, vol.56
, pp. 1134-1152
-
-
Ghaneh, P.1
Costello, E.2
Neoptolemos, J.P.3
-
22
-
-
80053439755
-
Oncolytic virotherapy for pancreatic cancer
-
Wennier S, Li S, McFadden G. 2011. Oncolytic virotherapy for pancreatic cancer. Expert Rev. Mol. Med. 13:e18. http://dx.doi.org/10.1017/S1462399411001876.
-
(2011)
Expert Rev. Mol. Med.
, vol.13
-
-
Wennier, S.1
Li, S.2
McFadden, G.3
-
23
-
-
34548250956
-
Parvoviral host range and cell entry mechanisms
-
Cotmore SF, Tattersall P. 2007. Parvoviral host range and cell entry mechanisms. Adv. Virus Res. 70:183-232. http://dx.doi.org/10.1016/S0065-3527(07)70005-2.
-
(2007)
Adv. Virus Res.
, vol.70
, pp. 183-232
-
-
Cotmore, S.F.1
Tattersall, P.2
-
24
-
-
85047696448
-
Suppression of metastatic hemangiosarcoma by a parvovirusMVMpvector transducing the IP-10 chemokine into immunocompetent mice
-
Giese NA, Raykov Z, DeMartino L, Vecchi A, Sozzani S, Dinsart C, Cornelis JJ, Rommelaere J. 2002. Suppression of metastatic hemangiosarcoma by a parvovirusMVMpvector transducing the IP-10 chemokine into immunocompetent mice. Cancer Gene Ther. 9:432-442. http://dx.doi.org/10.1038/sj.cgt.7700457.
-
(2002)
Cancer Gene Ther.
, vol.9
, pp. 432-442
-
-
Giese, N.A.1
Raykov, Z.2
DeMartino, L.3
Vecchi, A.4
Sozzani, S.5
Dinsart, C.6
Cornelis, J.J.7
Rommelaere, J.8
-
25
-
-
77953537989
-
Oncolytic parvoviruses as cancer therapeutics
-
Rommelaere J, Geletneky K, Angelova AL, Daeffler L, Dinsart C, Kiprianova I, Schlehofer JR, Raykov Z. 2010. Oncolytic parvoviruses as cancer therapeutics. Cytokine Growth Factor Rev. 21:185-195. http://dx.doi.org/10.1016/j.cytogfr.2010.02.011.
-
(2010)
Cytokine Growth Factor Rev.
, vol.21
, pp. 185-195
-
-
Rommelaere, J.1
Geletneky, K.2
Angelova, A.L.3
Daeffler, L.4
Dinsart, C.5
Kiprianova, I.6
Schlehofer, J.R.7
Raykov, Z.8
-
26
-
-
0035050285
-
Effective infection, apoptotic cell killing and gene transfer of human hepatoma cells but not primary hepatocytes by parvovirus H1 and derived vectors
-
Moehler M, Blechacz B, Weiskopf N, Zeidler M, Stremmel W, Rommelaere J, Galle PR, Cornelis JJ. 2001. Effective infection, apoptotic cell killing and gene transfer of human hepatoma cells but not primary hepatocytes by parvovirus H1 and derived vectors. Cancer Gene Ther. 8:158- 167. http://dx.doi.org/10.1038/sj.cgt.7700288.
-
(2001)
Cancer Gene Ther.
, vol.8
, pp. 158-167
-
-
Moehler, M.1
Blechacz, B.2
Weiskopf, N.3
Zeidler, M.4
Stremmel, W.5
Rommelaere, J.6
Galle, P.R.7
Cornelis, J.J.8
-
27
-
-
43049124141
-
Arming parvoviruses with CpG motifs to improve their oncosuppressive capacity
-
Raykov Z, Grekova S, Leuchs B, Aprahamian M, Rommelaere J. 2008. Arming parvoviruses with CpG motifs to improve their oncosuppressive capacity. Int. J. Cancer 122:2880-2884. http://dx.doi.org/10.1002/ijc.23472.
-
(2008)
Int. J. Cancer
, vol.122
, pp. 2880-2884
-
-
Raykov, Z.1
Grekova, S.2
Leuchs, B.3
Aprahamian, M.4
Rommelaere, J.5
-
28
-
-
34548052482
-
Combined oncolytic and vaccination activities of parvovirus H-1 in a metastatic tumor model
-
Raykov Z, Grekova S, Galabov AS, Balboni G, Koch U, Aprahamian M, Rommelaere J. 2007. Combined oncolytic and vaccination activities of parvovirus H-1 in a metastatic tumor model. Oncol. Rep. 17:1493- 1499. http://dx.doi.org/10.3892/or.17.6.1493.
-
(2007)
Oncol. Rep.
, vol.17
, pp. 1493-1499
-
-
Raykov, Z.1
Grekova, S.2
Galabov, A.S.3
Balboni, G.4
Koch, U.5
Aprahamian, M.6
Rommelaere, J.7
-
29
-
-
23844451373
-
Parvovirus H-1-induced tumor cell death enhances human immune response in vitro via increased phagocytosis, maturation, and cross-presentation by dendritic cells
-
Moehler MH, Zeidler M, Wilsberg V, Cornelis JJ, Woelfel T, Rommelaere J, Galle PR, Heike M. 2005. Parvovirus H-1-induced tumor cell death enhances human immune response in vitro via increased phagocytosis, maturation, and cross-presentation by dendritic cells. Hum. Gene Ther. 16:996-1005. http://dx.doi.org/10.1089/hum.2005.16.996.
-
(2005)
Hum. Gene Ther.
, vol.16
, pp. 996-1005
-
-
Moehler, M.H.1
Zeidler, M.2
Wilsberg, V.3
Cornelis, J.J.4
Woelfel, T.5
Rommelaere, J.6
Galle, P.R.7
Heike, M.8
-
30
-
-
82955239884
-
Activation of the human immune system by chemotherapeutic or targeted agents combined with the oncolytic parvovirus H-1
-
Moehler M, Sieben M, Roth S, Springsguth F, Leuchs B, Zeidler M, Dinsart C, Rommelaere J, Galle PR. 2011. Activation of the human immune system by chemotherapeutic or targeted agents combined with the oncolytic parvovirus H-1. BMC Cancer 11:464. http://dx.doi.org/10.1186/1471-2407-11-464.
-
(2011)
BMC Cancer
, vol.11
, pp. 464
-
-
Moehler, M.1
Sieben, M.2
Roth, S.3
Springsguth, F.4
Leuchs, B.5
Zeidler, M.6
Dinsart, C.7
Rommelaere, J.8
Galle, P.R.9
-
31
-
-
84863717012
-
Activation of a glioma-specific immune response by oncolytic parvovirus minute virus of mice infection
-
Grekova SP, Raykov Z, Zawatzky R, Rommelaere J, Koch U. 2012. Activation of a glioma-specific immune response by oncolytic parvovirus minute virus of mice infection. Cancer Gene Ther. 19:468-475. http://dx.doi.org/10.1038/cgt.2012.20.
-
(2012)
Cancer Gene Ther.
, vol.19
, pp. 468-475
-
-
Grekova, S.P.1
Raykov, Z.2
Zawatzky, R.3
Rommelaere, J.4
Koch, U.5
-
32
-
-
59449089665
-
Improvement of gemcitabine-based therapy of pancreatic carcinoma by means of oncolytic parvovirus H-1PV
-
Angelova AL, Aprahamian M, Grekova SP, Hajri A, Leuchs B, Giese NA, Dinsart C, Herrmann A, Balboni G, Rommelaere J, Raykov Z. 2009. Improvement of gemcitabine-based therapy of pancreatic carcinoma by means of oncolytic parvovirus H-1PV. Clin. Cancer Res. 15: 511-519. http://dx.doi.org/10.1158/1078-0432.CCR-08-1088.
-
(2009)
Clin. Cancer Res.
, vol.15
, pp. 511-519
-
-
Angelova, A.L.1
Aprahamian, M.2
Grekova, S.P.3
Hajri, A.4
Leuchs, B.5
Giese, N.A.6
Dinsart, C.7
Herrmann, A.8
Balboni, G.9
Rommelaere, J.10
Raykov, Z.11
-
33
-
-
77951933403
-
SMAD4: a predictive marker of PDAC cell permissiveness for oncolytic infection with parvovirus H-1PV
-
Dempe S, Stroh-Dege AY, Schwarz E, Rommelaere J, Dinsart C. 2010. SMAD4: a predictive marker of PDAC cell permissiveness for oncolytic infection with parvovirus H-1PV. Int. J. Cancer 126:2914-2927. http://dx.doi.org/10.1002/ijc.24992.
-
(2010)
Int. J. Cancer
, vol.126
, pp. 2914-2927
-
-
Dempe, S.1
Stroh-Dege, A.Y.2
Schwarz, E.3
Rommelaere, J.4
Dinsart, C.5
-
34
-
-
78650609261
-
Enhancement of NK cell antitumor responses using an oncolytic parvovirus
-
Bhat R, Dempe S, Dinsart C, Rommelaere J. 2011. Enhancement of NK cell antitumor responses using an oncolytic parvovirus. Int. J. Cancer 128:908-919. http://dx.doi.org/10.1002/ijc.25415.
-
(2011)
Int. J. Cancer
, vol.128
, pp. 908-919
-
-
Bhat, R.1
Dempe, S.2
Dinsart, C.3
Rommelaere, J.4
-
35
-
-
78650312207
-
Immune cells participate in the oncosuppressive activity of parvovirus H-1PV and are activated as a result of their abortive infection with this agent
-
Grekova S, Aprahamian M, Giese N, Schmitt S, Giese T, Falk CS, Daeffler L, Cziepluch C, Rommelaere J, Raykov Z. 2010. Immune cells participate in the oncosuppressive activity of parvovirus H-1PV and are activated as a result of their abortive infection with this agent. Cancer Biol. Ther. 10:1280-1289. http://dx.doi.org/10.4161/cbt.10.12.13455.
-
(2010)
Cancer Biol. Ther.
, vol.10
, pp. 1280-1289
-
-
Grekova, S.1
Aprahamian, M.2
Giese, N.3
Schmitt, S.4
Giese, T.5
Falk, C.S.6
Daeffler, L.7
Cziepluch, C.8
Rommelaere, J.9
Raykov, Z.10
-
36
-
-
81555222528
-
Interferon gamma improves the vaccination potential of oncolytic parvovirus H-1PV for the treatment of peritoneal carcinomatosis in pancreatic cancer
-
Grekova SP, Aprahamian M, Daeffler L, Leuchs B, Angelova A, Giese T, Galabov A, Heller A, Giese NA, Rommelaere J, Raykov Z. 2011. Interferon gamma improves the vaccination potential of oncolytic parvovirus H-1PV for the treatment of peritoneal carcinomatosis in pancreatic cancer. Cancer Biol. Ther. 12:888-895. http://dx.doi.org/10.4161/cbt.12.10.17678.
-
(2011)
Cancer Biol. Ther.
, vol.12
, pp. 888-895
-
-
Grekova, S.P.1
Aprahamian, M.2
Daeffler, L.3
Leuchs, B.4
Angelova, A.5
Giese, T.6
Galabov, A.7
Heller, A.8
Giese, N.A.9
Rommelaere, J.10
Raykov, Z.11
-
37
-
-
65349092744
-
Viral subversion of immunogenic cell death
-
Kepp O, Senovilla L, Galluzzi L, Panaretakis T, Tesniere A, Schlemmer F, Madeo F, Zitvogel L, Kroemer G. 2009. Viral subversion of immunogenic cell death. Cell Cycle 8:860-869. http://dx.doi.org/10.4161/cc.8.6.7939.
-
(2009)
Cell Cycle
, vol.8
, pp. 860-869
-
-
Kepp, O.1
Senovilla, L.2
Galluzzi, L.3
Panaretakis, T.4
Tesniere, A.5
Schlemmer, F.6
Madeo, F.7
Zitvogel, L.8
Kroemer, G.9
-
38
-
-
80052489035
-
Hepatitis C virus infection is blocked by HMGB1 released from virusinfected cells
-
Jung JH, Park JH, Jee MH, Keum SJ, Cho MS, Yoon SK, Jang SK. 2011. Hepatitis C virus infection is blocked by HMGB1 released from virusinfected cells. J. Virol. 85:9359-9368. http://dx.doi.org/10.1128/JVI.00682-11.
-
(2011)
J. Virol.
, vol.85
, pp. 9359-9368
-
-
Jung, J.H.1
Park, J.H.2
Jee, M.H.3
Keum, S.J.4
Cho, M.S.5
Yoon, S.K.6
Jang, S.K.7
-
39
-
-
84856745299
-
HMGB1, an alarmin promoting HIV dissemination and latency in dendritic cells
-
Gougeon ML, Melki MT, Saidi H. 2012. HMGB1, an alarmin promoting HIV dissemination and latency in dendritic cells. Cell Death Differ. 19:96-106. http://dx.doi.org/10.1038/cdd.2011.134.
-
(2012)
Cell Death Differ.
, vol.19
, pp. 96-106
-
-
Gougeon, M.L.1
Melki, M.T.2
Saidi, H.3
-
40
-
-
42049104455
-
Virus-mediated oncolysis induces danger signal and stimulates cytotoxic T-lymphocyte activity via proteasome activator upregulation
-
Endo Y, Sakai R, Ouchi M, Onimatsu H, Hioki M, Kagawa S, Uno F, Watanabe Y, Urata Y, Tanaka N, Fujiwara T. 2008. Virus-mediated oncolysis induces danger signal and stimulates cytotoxic T-lymphocyte activity via proteasome activator upregulation. Oncogene 27:2375-2381. http://dx.doi.org/10.1038/sj.onc.1210884.
-
(2008)
Oncogene
, vol.27
, pp. 2375-2381
-
-
Endo, Y.1
Sakai, R.2
Ouchi, M.3
Onimatsu, H.4
Hioki, M.5
Kagawa, S.6
Uno, F.7
Watanabe, Y.8
Urata, Y.9
Tanaka, N.10
Fujiwara, T.11
-
41
-
-
84871985834
-
Measles virus causes immunogenic cell death in human melanoma
-
Donnelly OG, Errington-Mais F, Steele L, Hadac E, Jennings V, Scott K, Peach H, Phillips RM, Bond J, Pandha H, Harrington K, Vile R, Russell S, Selby P, Melcher AA. 2013. Measles virus causes immunogenic cell death in human melanoma. Gene Ther. 20:7-15. http://dx.doi.org/10.1038/gt.2011.205.
-
(2013)
Gene Ther.
, vol.20
, pp. 7-15
-
-
Donnelly, O.G.1
Errington-Mais, F.2
Steele, L.3
Hadac, E.4
Jennings, V.5
Scott, K.6
Peach, H.7
Phillips, R.M.8
Bond, J.9
Pandha, H.10
Harrington, K.11
Vile, R.12
Russell, S.13
Selby, P.14
Melcher, A.A.15
-
42
-
-
84860520650
-
Immune response is an important aspect of the antitumor effect produced by a CD40L-encoding oncolytic adenovirus
-
Diaconu I, Cerullo V, Hirvinen ML, Escutenaire S, Ugolini M, Pesonen SK, Bramante S, Parviainen S, Kanerva A, Loskog AS, Eliopoulos AG, Pesonen S, Hemminki A. 2012. Immune response is an important aspect of the antitumor effect produced by a CD40L-encoding oncolytic adenovirus. Cancer Res. 72:2327-2338. http://dx.doi.org/10.1158/0008-5472.CAN-11-2975.
-
(2012)
Cancer Res.
, vol.72
, pp. 2327-2338
-
-
Diaconu, I.1
Cerullo, V.2
Hirvinen, M.L.3
Escutenaire, S.4
Ugolini, M.5
Pesonen, S.K.6
Bramante, S.7
Parviainen, S.8
Kanerva, A.9
Loskog, A.S.10
Eliopoulos, A.G.11
Pesonen, S.12
Hemminki, A.13
-
43
-
-
79951508366
-
Synergistic antitumor effects between oncolytic vaccinia virus and paclitaxel are mediated by the IFN response and HMGB1
-
Huang B, Sikorski R, Kirn DH, Thorne SH. 2011. Synergistic antitumor effects between oncolytic vaccinia virus and paclitaxel are mediated by the IFN response and HMGB1. Gene Ther. 18:164-172. http://dx.doi.org/10.1038/gt.2010.121.
-
(2011)
Gene Ther.
, vol.18
, pp. 164-172
-
-
Huang, B.1
Sikorski, R.2
Kirn, D.H.3
Thorne, S.H.4
-
44
-
-
84873818451
-
TLR-9 contributes to the antiviral innate immune sensing of rodent parvoviruses MVMp and H-1PV by normal human immune cells
-
Raykov Z, Grekova SP, Horlein R, Leuchs B, Giese T, Giese NA, Rommelaere J, Zawatzky R, Daeffler L. 2013. TLR-9 contributes to the antiviral innate immune sensing of rodent parvoviruses MVMp and H-1PV by normal human immune cells. PLoS One 8:e55086. http://dx.doi.org/10.1371/journal.pone.0055086.
-
(2013)
PLoS One
, vol.8
-
-
Raykov, Z.1
Grekova, S.P.2
Horlein, R.3
Leuchs, B.4
Giese, T.5
Giese, N.A.6
Rommelaere, J.7
Zawatzky, R.8
Daeffler, L.9
-
45
-
-
39749123276
-
Apoptosis and necrosis: detection, discrimination and phagocytosis
-
Krysko DV, Vanden Berghe T, D'Herde K, Vandenabeele P. 2008. Apoptosis and necrosis: detection, discrimination and phagocytosis. Methods 44:205-221. http://dx.doi.org/10.1016/j.ymeth.2007.12.001.
-
(2008)
Methods
, vol.44
, pp. 205-221
-
-
Krysko, D.V.1
Vanden Berghe, T.2
D'Herde, K.3
Vandenabeele, P.4
-
46
-
-
84879137186
-
Determination of apoptotic and necrotic cell death in vitro and in vivo
-
Vanden Berghe T, Grootjans S, Goossens V, Dondelinger Y, Krysko DV, Takahashi N, Vandenabeele P. 2013. Determination of apoptotic and necrotic cell death in vitro and in vivo. Methods 61:117-129. http://dx.doi.org/10.1016/j.ymeth.2013.02.011.
-
(2013)
Methods
, vol.61
, pp. 117-129
-
-
Vanden Berghe, T.1
Grootjans, S.2
Goossens, V.3
Dondelinger, Y.4
Krysko, D.V.5
Takahashi, N.6
Vandenabeele, P.7
-
47
-
-
0023856253
-
The NS-1 polypeptide of minute virus of mice is covalently attached to the 5' termini of duplex replicative-form DNA and progeny single strands
-
Cotmore SF, Tattersall P. 1988. The NS-1 polypeptide of minute virus of mice is covalently attached to the 5' termini of duplex replicative-form DNA and progeny single strands. J. Virol. 62:851-860.
-
(1988)
J. Virol
, vol.62
, pp. 851-860
-
-
Cotmore, S.F.1
Tattersall, P.2
-
48
-
-
34247170947
-
Cytosolic activation of cathepsins mediates parvovirus H-1-induced killing of cisplatin- and TRAILresistant glioma cells
-
Di Piazza M, Mader C, Geletneky K, Herrero YCM, Weber E, Schlehofer J, Deleu L, Rommelaere J. 2007. Cytosolic activation of cathepsins mediates parvovirus H-1-induced killing of cisplatin- and TRAILresistant glioma cells. J. Virol. 81:4186-4198. http://dx.doi.org/10.1128/JVI.02601-06.
-
(2007)
J. Virol.
, vol.81
, pp. 4186-4198
-
-
Di Piazza, M.1
Mader, C.2
Geletneky, K.3
Herrero, Y.C.M.4
Weber, E.5
Schlehofer, J.6
Deleu, L.7
Rommelaere, J.8
-
49
-
-
78650062665
-
Parvovirus infection-induced cell death and cell cycle arrest
-
Chen AY, Qiu J. 2010. Parvovirus infection-induced cell death and cell cycle arrest. Future Virol. 5:731-743. http://dx.doi.org/10.2217/fvl.10.56.
-
(2010)
Future Virol.
, vol.5
, pp. 731-743
-
-
Chen, A.Y.1
Qiu, J.2
-
50
-
-
0024393476
-
Inhibition by parvovirus H-1 of the formation of tumors in nude mice and colonies in vitro by transformed human mammary epithelial cells
-
Dupressoir T, Vanacker JM, Cornelis JJ, Duponchel N, Rommelaere J. 1989. Inhibition by parvovirus H-1 of the formation of tumors in nude mice and colonies in vitro by transformed human mammary epithelial cells. Cancer Res. 49:3203-3208.
-
(1989)
Cancer Res
, vol.49
, pp. 3203-3208
-
-
Dupressoir, T.1
Vanacker, J.M.2
Cornelis, J.J.3
Duponchel, N.4
Rommelaere, J.5
-
51
-
-
77952737333
-
Through its nonstructural protein NS1, parvovirus H-1 induces apoptosis via accumulation of reactive oxygen species
-
Hristov G, Kramer M, Li J, El-Andaloussi N, Mora R, Daeffler L, Zentgraf H, Rommelaere J, Marchini A. 2010. Through its nonstructural protein NS1, parvovirus H-1 induces apoptosis via accumulation of reactive oxygen species. J. Virol. 84:5909-5922. http://dx.doi.org/10.1128/JVI.01797-09.
-
(2010)
J. Virol.
, vol.84
, pp. 5909-5922
-
-
Hristov, G.1
Kramer, M.2
Li, J.3
El-Andaloussi, N.4
Mora, R.5
Daeffler, L.6
Zentgraf, H.7
Rommelaere, J.8
Marchini, A.9
-
52
-
-
0032743996
-
Parvovirus H-1-induced cell death: influence of intracellularNADconsumption on the regulation of necrosis and apoptosis
-
Ran Z, Rayet B, Rommelaere J, Faisst S. 1999. Parvovirus H-1-induced cell death: influence of intracellularNADconsumption on the regulation of necrosis and apoptosis. Virus Res. 65:161-174. http://dx.doi.org/10.1016/S0168-1702(99)00115-X.
-
(1999)
Virus Res.
, vol.65
, pp. 161-174
-
-
Ran, Z.1
Rayet, B.2
Rommelaere, J.3
Faisst, S.4
-
53
-
-
0031691259
-
Induction of programmed cell death by parvovirus H-1 in U937 cells: connection with the tumor necrosis factor alpha signalling pathway
-
Rayet B, Lopez-Guerrero JA, Rommelaere J, Dinsart C. 1998. Induction of programmed cell death by parvovirus H-1 in U937 cells: connection with the tumor necrosis factor alpha signalling pathway. J. Virol. 72:8893-8903.
-
(1998)
J. Virol
, vol.72
, pp. 8893-8903
-
-
Rayet, B.1
Lopez-Guerrero, J.A.2
Rommelaere, J.3
Dinsart, C.4
-
54
-
-
79961126311
-
Discrimination between primary necrosis and apoptosis by necrostatin-1 in annexin V-positive/propidium iodidenegative cells
-
Sawai H, Domae N. 2011. Discrimination between primary necrosis and apoptosis by necrostatin-1 in annexin V-positive/propidium iodidenegative cells. Biochem. Biophys. Res. Commun. 411:569-573. http://dx.doi.org/10.1016/j.bbrc.2011.06.186.
-
(2011)
Biochem. Biophys. Res. Commun.
, vol.411
, pp. 569-573
-
-
Sawai, H.1
Domae, N.2
-
55
-
-
84874263775
-
Necroptosis: the release of damage-associated molecular patterns and its physiological relevance
-
Kaczmarek A, Vandenabeele P, Krysko DV. 2013. Necroptosis: the release of damage-associated molecular patterns and its physiological relevance. Immunity 38:209-223. http://dx.doi.org/10.1016/j.immuni.2013.02.003.
-
(2013)
Immunity
, vol.38
, pp. 209-223
-
-
Kaczmarek, A.1
Vandenabeele, P.2
Krysko, D.V.3
-
56
-
-
58449083290
-
Pyroptosis: host cell death and inflammation
-
Bergsbaken T, Fink SL, Cookson BT. 2009. Pyroptosis: host cell death and inflammation. Nat. Rev. Microbiol. 7:99-109. http://dx.doi.org/10.1038/nrmicro2070.
-
(2009)
Nat. Rev. Microbiol.
, vol.7
, pp. 99-109
-
-
Bergsbaken, T.1
Fink, S.L.2
Cookson, B.T.3
-
57
-
-
16244362671
-
Apoptosis, pyroptosis, and necrosis: mechanistic description of dead and dying eukaryotic cells
-
Fink SL, Cookson BT. 2005. Apoptosis, pyroptosis, and necrosis: mechanistic description of dead and dying eukaryotic cells. Infect. Immun. 73:1907-1916. http://dx.doi.org/10.1128/IAI.73.4.1907-1916.2005.
-
(2005)
Infect. Immun.
, vol.73
, pp. 1907-1916
-
-
Fink, S.L.1
Cookson, B.T.2
-
58
-
-
80052179138
-
Caspase-1-induced pyroptotic cell death
-
Miao EA, Rajan JV, Aderem A. 2011. Caspase-1-induced pyroptotic cell death. Immunol. Rev. 243:206-214. http://dx.doi.org/10.1111/j.1600-065X.2011.01044.x.
-
(2011)
Immunol. Rev.
, vol.243
, pp. 206-214
-
-
Miao, E.A.1
Rajan, J.V.2
Aderem, A.3
-
59
-
-
57649167477
-
Necroptosis: a specialized pathway of programmed necrosis
-
Galluzzi L, Kroemer G. 2008. Necroptosis: a specialized pathway of programmed necrosis. Cell 135:1161-1163. http://dx.doi.org/10.1016/j.cell.2008.12.004.
-
(2008)
Cell
, vol.135
, pp. 1161-1163
-
-
Galluzzi, L.1
Kroemer, G.2
-
60
-
-
77749260612
-
Pyroptosis-a cell death modality of its kind? Eur
-
Kepp O, Galluzzi L, Zitvogel L, Kroemer G. 2010. Pyroptosis-a cell death modality of its kind? Eur. J. Immunol. 40:627-630. http://dx.doi.org/10.1002/eji.200940160.
-
(2010)
J. Immunol.
, vol.40
, pp. 627-630
-
-
Kepp, O.1
Galluzzi, L.2
Zitvogel, L.3
Kroemer, G.4
-
61
-
-
80054108848
-
Protein release through nonlethal oncotic pores as an alternative nonclassical secretory pathway
-
Chirico WJ. 2011. Protein release through nonlethal oncotic pores as an alternative nonclassical secretory pathway. BMC Cell Biol. 12:46. http://dx.doi.org/10.1186/1471-2121-12-46.
-
(2011)
BMC Cell Biol.
, vol.12
, pp. 46
-
-
Chirico, W.J.1
-
62
-
-
4544361834
-
Nuclear export of the nonenveloped parvovirus virion is directed by an unordered protein signal exposed on the capsid surface
-
Maroto B, Valle N, Saffrich R, Almendral JM. 2004. Nuclear export of the nonenveloped parvovirus virion is directed by an unordered protein signal exposed on the capsid surface. J. Virol. 78:10685-10694. http://dx.doi.org/10.1128/JVI.78.19.10685-10694.2004.
-
(2004)
J. Virol.
, vol.78
, pp. 10685-10694
-
-
Maroto, B.1
Valle, N.2
Saffrich, R.3
Almendral, J.M.4
-
63
-
-
34547629250
-
A viral adaptor protein modulating casein kinase II activity induces cytopathic effects in permissive cells
-
Nuesch JP, Rommelaere J. 2007. A viral adaptor protein modulating casein kinase II activity induces cytopathic effects in permissive cells. Proc. Natl. Acad. Sci. U. S. A. 104:12482-12487. http://dx.doi.org/10.1073/pnas.0705533104.
-
(2007)
Proc. Natl. Acad. Sci. U. S. A.
, vol.104
, pp. 12482-12487
-
-
Nuesch, J.P.1
Rommelaere, J.2
-
64
-
-
84884691678
-
Distinct host cell fates for human malignant melanoma targeted by oncolytic rodent parvoviruses
-
Vollmers EM, Tattersall P. 2013. Distinct host cell fates for human malignant melanoma targeted by oncolytic rodent parvoviruses. Virology 446:37-48. http://dx.doi.org/10.1016/j.virol.2013.07.013.
-
(2013)
Virology
, vol.446
, pp. 37-48
-
-
Vollmers, E.M.1
Tattersall, P.2
-
65
-
-
84861671713
-
Lysosomal pathways to cell death and their therapeutic applications
-
Cesen MH, Pegan K, Spes A, Turk B. 2012. Lysosomal pathways to cell death and their therapeutic applications. Exp. Cell Res. 318:1245-1251. http://dx.doi.org/10.1016/j.yexcr.2012.03.005.
-
(2012)
Exp. Cell Res.
, vol.318
, pp. 1245-1251
-
-
Cesen, M.H.1
Pegan, K.2
Spes, A.3
Turk, B.4
-
66
-
-
78449308794
-
Danger signaling protein HMGB1 induces a distinct form of cell death accompanied by formation of giant mitochondria
-
Gdynia G, Keith M, Kopitz J, Bergmann M, Fassl A, Weber AN, George J, Kees T, Zentgraf HW, Wiestler OD, Schirmacher P, Roth W. 2010. Danger signaling protein HMGB1 induces a distinct form of cell death accompanied by formation of giant mitochondria. Cancer Res. 70:8558-8568. http://dx.doi.org/10.1158/0008-5472.CAN-10-0204.
-
(2010)
Cancer Res.
, vol.70
, pp. 8558-8568
-
-
Gdynia, G.1
Keith, M.2
Kopitz, J.3
Bergmann, M.4
Fassl, A.5
Weber, A.N.6
George, J.7
Kees, T.8
Zentgraf, H.W.9
Wiestler, O.D.10
Schirmacher, P.11
Roth, W.12
-
67
-
-
0037062934
-
Release of chromatin protein HMGB1 by necrotic cells triggers inflammation
-
Scaffidi P, Misteli T, Bianchi ME. 2002. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 418:191-195. http://dx.doi.org/10.1038/nature00858.
-
(2002)
Nature
, vol.418
, pp. 191-195
-
-
Scaffidi, P.1
Misteli, T.2
Bianchi, M.E.3
-
68
-
-
2942735137
-
Significant (re)location: how to use chromatin and/or abundant proteins as messages of life and death
-
Bianchi ME. 2004. Significant (re)location: how to use chromatin and/or abundant proteins as messages of life and death. Trends Cell Biol. 14: 287-293. http://dx.doi.org/10.1016/j.tcb.2004.04.004.
-
(2004)
Trends Cell Biol.
, vol.14
, pp. 287-293
-
-
Bianchi, M.E.1
-
69
-
-
1542345501
-
Regulated expression and subcellular localization of HMGB1, a chromatin protein with a cytokine function
-
Muller S, Ronfani L, Bianchi ME. 2004. Regulated expression and subcellular localization of HMGB1, a chromatin protein with a cytokine function. J. Intern. Med. 255:332-343. http://dx.doi.org/10.1111/j.1365-2796.2003.01296.x.
-
(2004)
J. Intern. Med.
, vol.255
, pp. 332-343
-
-
Muller, S.1
Ronfani, L.2
Bianchi, M.E.3
-
70
-
-
84879651810
-
Life after death: targeting high mobility group box 1 in emergent cancer therapies
-
Guo ZS, Liu Z, Bartlett DL, Tang D, Lotze MT. 2013. Life after death: targeting high mobility group box 1 in emergent cancer therapies. Am. J. Cancer Res. 3:1-20.
-
(2013)
Am. J. Cancer Res
, vol.3
, pp. 1-20
-
-
Guo, Z.S.1
Liu, Z.2
Bartlett, D.L.3
Tang, D.4
Lotze, M.T.5
-
71
-
-
0142137129
-
Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion
-
Bonaldi T, Talamo F, Scaffidi P, Ferrera D, Porto A, Bachi A, Rubartelli A, Agresti A, Bianchi ME. 2003. Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion. EMBO J. 22:5551-5560. http://dx.doi.org/10.1093/emboj/cdg516.
-
(2003)
EMBO J.
, vol.22
, pp. 5551-5560
-
-
Bonaldi, T.1
Talamo, F.2
Scaffidi, P.3
Ferrera, D.4
Porto, A.5
Bachi, A.6
Rubartelli, A.7
Agresti, A.8
Bianchi, M.E.9
-
72
-
-
0036775236
-
The nuclear protein HMGB1 is secreted by monocytes via a non-classical, vesicle-mediated secretory pathway
-
Gardella S, Andrei C, Ferrera D, Lotti LV, Torrisi MR, Bianchi ME, Rubartelli A. 2002. The nuclear protein HMGB1 is secreted by monocytes via a non-classical, vesicle-mediated secretory pathway. EMBO Rep. 3:995-1001. http://dx.doi.org/10.1093/embo-reports/kvf198.
-
(2002)
EMBO Rep.
, vol.3
, pp. 995-1001
-
-
Gardella, S.1
Andrei, C.2
Ferrera, D.3
Lotti, L.V.4
Torrisi, M.R.5
Bianchi, M.E.6
Rubartelli, A.7
-
73
-
-
84865511926
-
Novel role of PKR in inflammasome activation and HMGB1 release
-
Lu B, Nakamura T, Inouye K, Li J, Tang Y, Lundback P, Valdes-Ferrer SI, Olofsson PS, Kalb T, Roth J, Zou Y, Erlandsson-Harris H, Yang H, Ting JP, Wang H, Andersson U, Antoine DJ, Chavan SS, Hotamisligil GS, Tracey KJ. 2012. Novel role of PKR in inflammasome activation and HMGB1 release. Nature 488:670-674. http://dx.doi.org/10.1038/nature11290.
-
(2012)
Nature
, vol.488
, pp. 670-674
-
-
Lu, B.1
Nakamura, T.2
Inouye, K.3
Li, J.4
Tang, Y.5
Lundback, P.6
Valdes-Ferrer, S.I.7
Olofsson, P.S.8
Kalb, T.9
Roth, J.10
Zou, Y.11
Erlandsson-Harris, H.12
Yang, H.13
Ting, J.P.14
Wang, H.15
Andersson, U.16
Antoine, D.J.17
Chavan, S.S.18
Hotamisligil, G.S.19
Tracey, K.J.20
more..
-
74
-
-
68149100523
-
NLRP3 (NALP3, cryopyrin) facilitates in vivo caspase-1 activation, necrosis, and HMGB1 release via inflammasome-dependent and -independent pathways
-
Willingham SB, Allen IC, Bergstralh DT, Brickey WJ, Huang MT, Taxman DJ, Duncan JA, Ting JP. 2009. NLRP3 (NALP3, cryopyrin) facilitates in vivo caspase-1 activation, necrosis, and HMGB1 release via inflammasome-dependent and -independent pathways. J. Immunol. 183:2008-2015. http://dx.doi.org/10.4049/jimmunol.0900138.
-
(2009)
J. Immunol.
, vol.183
, pp. 2008-2015
-
-
Willingham, S.B.1
Allen, I.C.2
Bergstralh, D.T.3
Brickey, W.J.4
Huang, M.T.5
Taxman, D.J.6
Duncan, J.A.7
Ting, J.P.8
-
75
-
-
84872086179
-
Chemotherapytriggered cathepsin B release in myeloid-derived suppressor cells activates the Nlrp3 inflammasome and promotes tumor growth
-
Bruchard M, Mignot G, Derangere V, Chalmin F, Chevriaux A, Vegran F, Boireau W, Simon B, Ryffel B, Connat JL, Kanellopoulos J, Martin F, Rebe C, Apetoh L, Ghiringhelli F. 2013. Chemotherapytriggered cathepsin B release in myeloid-derived suppressor cells activates the Nlrp3 inflammasome and promotes tumor growth. Nat. Med. 19:57-64. http://dx.doi.org/10.1038/nm.2999.
-
(2013)
Nat. Med.
, vol.19
, pp. 57-64
-
-
Bruchard, M.1
Mignot, G.2
Derangere, V.3
Chalmin, F.4
Chevriaux, A.5
Vegran, F.6
Boireau, W.7
Simon, B.8
Ryffel, B.9
Connat, J.L.10
Kanellopoulos, J.11
Martin, F.12
Rebe, C.13
Apetoh, L.14
Ghiringhelli, F.15
-
76
-
-
78650067155
-
High mobility group box 1 release from hepatocytes during ischemia and reperfusion injury is mediated by decreased histone deacetylase activity
-
Evankovich J, Cho SW, Zhang R, Cardinal J, Dhupar R, Zhang L, Klune JR, Zlotnicki J, Billiar T, Tsung A. 2010. High mobility group box 1 release from hepatocytes during ischemia and reperfusion injury is mediated by decreased histone deacetylase activity. J. Biol. Chem. 285: 39888-39897. http://dx.doi.org/10.1074/jbc.M110.128348.
-
(2010)
J. Biol. Chem.
, vol.285
, pp. 39888-39897
-
-
Evankovich, J.1
Cho, S.W.2
Zhang, R.3
Cardinal, J.4
Dhupar, R.5
Zhang, L.6
Klune, J.R.7
Zlotnicki, J.8
Billiar, T.9
Tsung, A.10
-
77
-
-
79959956124
-
Gemcitabine/cannabinoid combination triggers autophagy in pancreatic cancer cells through a ROSmediated mechanism
-
Donadelli M, Dando I, Zaniboni T, Costanzo C, Dalla Pozza E, Scupoli MT, Scarpa A, Zappavigna S, Marra M, Abbruzzese A, Bifulco M, Caraglia M, Palmieri M. 2011. Gemcitabine/cannabinoid combination triggers autophagy in pancreatic cancer cells through a ROSmediated mechanism. Cell Death Dis. 2:e152. http://dx.doi.org/10.1038/cddis.2011.36.
-
(2011)
Cell Death Dis.
, vol.2
-
-
Donadelli, M.1
Dando, I.2
Zaniboni, T.3
Costanzo, C.4
Dalla Pozza, E.5
Scupoli, M.T.6
Scarpa, A.7
Zappavigna, S.8
Marra, M.9
Abbruzzese, A.10
Bifulco, M.11
Caraglia, M.12
Palmieri, M.13
-
78
-
-
0034624998
-
Cyclin A activates the DNA polymerase delta-dependent elongation machinery in vitro: a parvovirus DNA replication model
-
Bashir T, Horlein R, Rommelaere J, Willwand K. 2000. Cyclin A activates the DNA polymerase delta-dependent elongation machinery in vitro: a parvovirus DNA replication model. Proc. Natl. Acad. Sci. U. S. A. 97:5522-5527. http://dx.doi.org/10.1073/pnas.090485297.
-
(2000)
Proc. Natl. Acad. Sci. U. S. A.
, vol.97
, pp. 5522-5527
-
-
Bashir, T.1
Horlein, R.2
Rommelaere, J.3
Willwand, K.4
-
79
-
-
0035426936
-
Cell cycle effects of gemcitabine
-
Cappella P, Tomasoni D, Faretta M, Lupi M, Montalenti F, Viale F, Banzato F, D'Incalci M, Ubezio P. 2001. Cell cycle effects of gemcitabine. Int. J. Cancer 93:401-408. http://dx.doi.org/10.1002/ijc.1351.
-
(2001)
Int. J. Cancer
, vol.93
, pp. 401-408
-
-
Cappella, P.1
Tomasoni, D.2
Faretta, M.3
Lupi, M.4
Montalenti, F.5
Viale, F.6
Banzato, F.7
D'Incalci, M.8
Ubezio, P.9
-
80
-
-
79952282257
-
Aurora B kinase inhibitor AZD1152: determinants of action and ability to enhance chemotherapeutics effectiveness in pancreatic and colon cancer
-
Azzariti A, Bocci G, Porcelli L, Fioravanti A, Sini P, Simone GM, Quatrale AE, Chiarappa P, Mangia A, Sebastian S, Del Bufalo D, Del Tacca M, Paradiso A. 2011. Aurora B kinase inhibitor AZD1152: determinants of action and ability to enhance chemotherapeutics effectiveness in pancreatic and colon cancer. Br. J. Cancer 104:769-780. http://dx.doi.org/10.1038/bjc.2011.21.
-
(2011)
Br. J. Cancer
, vol.104
, pp. 769-780
-
-
Azzariti, A.1
Bocci, G.2
Porcelli, L.3
Fioravanti, A.4
Sini, P.5
Simone, G.M.6
Quatrale, A.E.7
Chiarappa, P.8
Mangia, A.9
Sebastian, S.10
Del Bufalo, D.11
Del Tacca, M.12
Paradiso, A.13
-
81
-
-
0142217877
-
Cell cycle effect of gemcitabine and its role in the radiosensitizing mechanism in vitro
-
Pauwels B, Korst AE, Pattyn GG, Lambrechts HA, Van Bockstaele DR, Vermeulen K, Lenjou M, de Pooter CM, Vermorken JB, Lardon F. 2003. Cell cycle effect of gemcitabine and its role in the radiosensitizing mechanism in vitro. Int. J. Radiat. Oncol. Biol. Phys. 57:1075-1083. http://dx.doi.org/10.1016/S0360-3016(03)01443-3.
-
(2003)
Int. J. Radiat. Oncol. Biol. Phys.
, vol.57
, pp. 1075-1083
-
-
Pauwels, B.1
Korst, A.E.2
Pattyn, G.G.3
Lambrechts, H.A.4
Van Bockstaele, D.R.5
Vermeulen, K.6
Lenjou, M.7
de Pooter, C.M.8
Vermorken, J.B.9
Lardon, F.10
-
82
-
-
35748942876
-
The interaction between HMGB1 and TLR4 dictates the outcome of anticancer chemotherapy and radiotherapy
-
Apetoh L, Ghiringhelli F, Tesniere A, Criollo A, Ortiz C, Lidereau R, Mariette C, Chaput N, Mira JP, Delaloge S, Andre F, Tursz T, Kroemer G, Zitvogel L. 2007. The interaction between HMGB1 and TLR4 dictates the outcome of anticancer chemotherapy and radiotherapy. Immunol. Rev. 220:47-59. http://dx.doi.org/10.1111/j.1600-065X.2007.00573.x.
-
(2007)
Immunol. Rev.
, vol.220
, pp. 47-59
-
-
Apetoh, L.1
Ghiringhelli, F.2
Tesniere, A.3
Criollo, A.4
Ortiz, C.5
Lidereau, R.6
Mariette, C.7
Chaput, N.8
Mira, J.P.9
Delaloge, S.10
Andre, F.11
Tursz, T.12
Kroemer, G.13
Zitvogel, L.14
-
83
-
-
77952298772
-
HMGB1 and RAGE in inflammation and cancer
-
Sims GP, Rowe DC, Rietdijk ST, Herbst R, Coyle AJ. 2010. HMGB1 and RAGE in inflammation and cancer. Annu. Rev. Immunol. 28:367- 388. http://dx.doi.org/10.1146/annurev.immunol.021908.132603.
-
(2010)
Annu. Rev. Immunol.
, vol.28
-
-
Sims, G.P.1
Rowe, D.C.2
Rietdijk, S.T.3
Herbst, R.4
Coyle, A.J.5
-
84
-
-
67650360785
-
Release of HMGB1 in response to proapoptotic glioma killing strategies: efficacy and neurotoxicity
-
Candolfi M, Yagiz K, Foulad D, Alzadeh GE, Tesarfreund M, Muhammad AK, Puntel M, Kroeger KM, Liu C, Lee S, Curtin JF, King GD, Lerner J, Sato K, Mineharu Y, Xiong W, Lowenstein PR, Castro MG. 2009. Release of HMGB1 in response to proapoptotic glioma killing strategies: efficacy and neurotoxicity. Clin. Cancer Res. 15:4401-4414. http://dx.doi.org/10.1158/1078-0432.CCR-09-0155.
-
(2009)
Clin. Cancer Res.
, vol.15
, pp. 4401-4414
-
-
Candolfi, M.1
Yagiz, K.2
Foulad, D.3
Alzadeh, G.E.4
Tesarfreund, M.5
Muhammad, A.K.6
Puntel, M.7
Kroeger, K.M.8
Liu, C.9
Lee, S.10
Curtin, J.F.11
King, G.D.12
Lerner, J.13
Sato, K.14
Mineharu, Y.15
Xiong, W.16
Lowenstein, P.R.17
Castro, M.G.18
-
86
-
-
34547766970
-
High mobility group box I (HMGB1) release from tumor cells after treatment: implications for development of targeted chemoimmunotherapy
-
Dong Xda E, Ito N, Lotze MT, Demarco RA, Popovic P, Shand SH, Watkins S, Winikoff S, Brown CK, Bartlett DL, Zeh HJ, 3rd. 2007. High mobility group box I (HMGB1) release from tumor cells after treatment: implications for development of targeted chemoimmunotherapy. J. Immunother. 30:596-606. http://dx.doi.org/10.1097/CJI.0b013e31804efc76.
-
(2007)
J. Immunother
, vol.30
, pp. 596-606
-
-
Dong Xda, E.1
Ito, N.2
Lotze, M.T.3
Demarco, R.A.4
Popovic, P.5
Shand, S.H.6
Watkins, S.7
Winikoff, S.8
Brown, C.K.9
Bartlett, D.L.10
Zeh, H.J.3rd.11
-
87
-
-
67650115009
-
Parvovirus induced alterations in nuclear architecture and dynamics
-
Ihalainen TO, Niskanen EA, Jylhava J, Paloheimo O, Dross N, Smolander H, Langowski J, Timonen J, Vihinen-Ranta M. 2009. Parvovirus induced alterations in nuclear architecture and dynamics. PLoS One 4:e5948. http://dx.doi.org/10.1371/journal.pone.0005948.
-
(2009)
PLoS One
, vol.4
-
-
Ihalainen, T.O.1
Niskanen, E.A.2
Jylhava, J.3
Paloheimo, O.4
Dross, N.5
Smolander, H.6
Langowski, J.7
Timonen, J.8
Vihinen-Ranta, M.9
-
88
-
-
21644483935
-
Parvovirus nonstructural proteins induce an epigenetic modification through histone acetylation in host genes and revert tumor malignancy to benignancy
-
Iseki H, Shimizukawa R, Sugiyama F, Kunita S, Iwama A, Onodera M, Nakauchi H, Yagami K. 2005. Parvovirus nonstructural proteins induce an epigenetic modification through histone acetylation in host genes and revert tumor malignancy to benignancy. J. Virol. 79:8886-8893. http://dx.doi.org/10.1128/JVI.79.14.8886-8893.2005.
-
(2005)
J. Virol.
, vol.79
, pp. 8886-8893
-
-
Iseki, H.1
Shimizukawa, R.2
Sugiyama, F.3
Kunita, S.4
Iwama, A.5
Onodera, M.6
Nakauchi, H.7
Yagami, K.8
-
89
-
-
0030920239
-
The NS1 protein of the autonomous parvovirus minute virus of mice blocks cellular DNA replication: a consequence of lesions to the chromatin?
-
Op De Beeck A, Caillet-Fauquet P. 1997. The NS1 protein of the autonomous parvovirus minute virus of mice blocks cellular DNA replication: a consequence of lesions to the chromatin? J. Virol. 71:5323-5329.
-
(1997)
J. Virol
, vol.71
, pp. 5323-5329
-
-
Op De Beeck, A.1
Caillet-Fauquet, P.2
-
90
-
-
0033977269
-
Two widely spaced initiator binding sites create an HMG1-dependent parvovirus rollinghairpin replication origin
-
Cotmore SF, Christensen J, Tattersall P. 2000. Two widely spaced initiator binding sites create an HMG1-dependent parvovirus rollinghairpin replication origin. J. Virol. 74:1332-1341. http://dx.doi.org/10.1128/JVI.74.3.1332-1341.2000.
-
(2000)
J. Virol.
, vol.74
, pp. 1332-1341
-
-
Cotmore, S.F.1
Christensen, J.2
Tattersall, P.3
-
91
-
-
84892746507
-
Caspase-1: the inflammasome and beyond
-
Sollberger G, Strittmatter GE, Garstkiewicz M, Sand J, Beer HD. 2014. Caspase-1: the inflammasome and beyond. Innate Immun. 20:115-125. http://dx.doi.org/10.1177/1753425913484374.
-
(2014)
Innate Immun.
, vol.20
, pp. 115-125
-
-
Sollberger, G.1
Strittmatter, G.E.2
Garstkiewicz, M.3
Sand, J.4
Beer, H.D.5
-
92
-
-
84864883030
-
Caspase-1: is IL-1 just the tip of the ICEberg?
-
Denes A, Lopez-Castejon G, Brough D. 2012. Caspase-1: is IL-1 just the tip of the ICEberg? Cell Death Dis. 3:e338. http://dx.doi.org/10.1038/cddis.2012.86.
-
(2012)
Cell Death Dis.
, vol.3
-
-
Denes, A.1
Lopez-Castejon, G.2
Brough, D.3
-
93
-
-
75649106430
-
Intracellular DNA recognition
-
Hornung V, Latz E. 2010. Intracellular DNA recognition. Nat. Rev. Immunol. 10:123-130. http://dx.doi.org/10.1038/nri2690.
-
(2010)
Nat. Rev. Immunol.
, vol.10
, pp. 123-130
-
-
Hornung, V.1
Latz, E.2
-
94
-
-
0032105492
-
Interleukin 1beta-converting enzyme (caspase-1) is overexpressed in adenocarcinoma of the pancreas
-
Gansauge S, Gansauge F, Yang Y, Muller J, Seufferlein T, Ramadani M, Beger HG. 1998. Interleukin 1beta-converting enzyme (caspase-1) is overexpressed in adenocarcinoma of the pancreas. Cancer Res. 58:2703-2706.
-
(1998)
Cancer Res
, vol.58
, pp. 2703-2706
-
-
Gansauge, S.1
Gansauge, F.2
Yang, Y.3
Muller, J.4
Seufferlein, T.5
Ramadani, M.6
Beger, H.G.7
-
95
-
-
0035431876
-
A viral phospholipase A2 is required for parvovirus infectivity
-
Zadori Z, Szelei J, Lacoste MC, Li Y, Gariepy S, Raymond P, Allaire M, Nabi IR, Tijssen P. 2001. A viral phospholipase A2 is required for parvovirus infectivity. Dev. Cell 1:291-302. http://dx.doi.org/10.1016/S1534-5807(01)00031-4.
-
(2001)
Dev. Cell
, vol.1
, pp. 291-302
-
-
Zadori, Z.1
Szelei, J.2
Lacoste, M.C.3
Li, Y.4
Gariepy, S.5
Raymond, P.6
Allaire, M.7
Nabi, I.R.8
Tijssen, P.9
-
96
-
-
50849129909
-
Vesicular egress of non-enveloped lytic parvoviruses depends on gelsolin functioning
-
Bar S, Daeffler L, Rommelaere J, Nuesch JP. 2008. Vesicular egress of non-enveloped lytic parvoviruses depends on gelsolin functioning. PLoS Pathog. 4:e1000126. http://dx.doi.org/10.1371/journal.ppat.1000126.
-
(2008)
PLoS Pathog.
, vol.4
-
-
Bar, S.1
Daeffler, L.2
Rommelaere, J.3
Nuesch, J.P.4
-
97
-
-
77951471913
-
Translation control by protein kinase R restricts minute virus of mice infection: role in parvovirus oncolysis
-
Ventoso I, Berlanga JJ, Almendral JM. 2010. Translation control by protein kinase R restricts minute virus of mice infection: role in parvovirus oncolysis. J. Virol. 84:5043-5051. http://dx.doi.org/10.1128/JVI.02188-09.
-
(2010)
J. Virol.
, vol.84
, pp. 5043-5051
-
-
Ventoso, I.1
Berlanga, J.J.2
Almendral, J.M.3
-
98
-
-
84875601707
-
Activation of the human immune system via Toll-like receptors by the oncolytic parvovirus H-1
-
Sieben M, Schafer P, Dinsart C, Galle PR, Moehler M. 2013. Activation of the human immune system via Toll-like receptors by the oncolytic parvovirus H-1. Int. J. Cancer 132:2548-2556. http://dx.doi.org/10.1002/ijc.27938.
-
(2013)
Int. J. Cancer
, vol.132
, pp. 2548-2556
-
-
Sieben, M.1
Schafer, P.2
Dinsart, C.3
Galle, P.R.4
Moehler, M.5
-
99
-
-
84878901796
-
Parvovirus evades interferon-dependent viral control in primary mouse embryonic fibroblasts
-
Mattei LM, Cotmore SF, Tattersall P, Iwasaki A. 2013. Parvovirus evades interferon-dependent viral control in primary mouse embryonic fibroblasts. Virology 442:20-27. http://dx.doi.org/10.1016/j.virol.2013.03.020.
-
(2013)
Virology
, vol.442
, pp. 20-27
-
-
Mattei, L.M.1
Cotmore, S.F.2
Tattersall, P.3
Iwasaki, A.4
-
100
-
-
84874745794
-
Toll-like receptor 9 in plasmacytoid dendritic cells fails to detect parvoviruses
-
Mattei LM, Cotmore SF, Li L, Tattersall P, Iwasaki A. 2013. Toll-like receptor 9 in plasmacytoid dendritic cells fails to detect parvoviruses. J. Virol. 87:3605-3608. http://dx.doi.org/10.1128/JVI.03155-12.
-
(2013)
J. Virol.
, vol.87
, pp. 3605-3608
-
-
Mattei, L.M.1
Cotmore, S.F.2
Li, L.3
Tattersall, P.4
Iwasaki, A.5
|